These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33297341)

  • 41. Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial.
    Tawinprai K; Siripongboonsitti T; Porntharukchareon T; Wittayasak K; Thonwirak N; Soonklang K; Sornsamdang G; Auewarakul C; Mahanonda N
    Vaccine; 2022 Mar; 40(12):1761-1767. PubMed ID: 35210118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunotherapeutic Effects of Different Doses of
    Liang Y; Cui L; Xiao L; Liu X; Yang Y; Ling Y; Wang T; Wang L; Wang J; Wu X
    Front Immunol; 2022; 13():876579. PubMed ID: 35603155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).
    Launay O; Surenaud M; Desaint C; Ben Hamouda N; Pialoux G; Bonnet B; Poizot-Martin I; Gonzales G; Cuzin L; Bourgault-Villada I; Lévy Y; Choppin J; Durier C
    Vaccine; 2013 Sep; 31(40):4406-15. PubMed ID: 23850610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
    Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
    Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators.
    Foy JE; Hendriksz T; Malouf P; Tobin A
    J Am Osteopath Assoc; 2013 Feb; 113(2):134-43. PubMed ID: 23412675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.
    Currier JR; Ngauy V; de Souza MS; Ratto-Kim S; Cox JH; Polonis VR; Earl P; Moss B; Peel S; Slike B; Sriplienchan S; Thongcharoen P; Paris RM; Robb ML; Kim J; Michael NL; Marovich MA
    PLoS One; 2010 Nov; 5(11):e13983. PubMed ID: 21085591
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals.
    Morrow MP; Tebas P; Yan J; Ramirez L; Slager A; Kraynyak K; Diehl M; Shah D; Khan A; Lee J; Boyer J; Kim JJ; Sardesai NY; Weiner DB; Bagarazzi ML
    Mol Ther; 2015 Mar; 23(3):591-601. PubMed ID: 25531694
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers.
    Henderson EA; Louie TJ; Ramotar K; Ledgerwood D; Hope KM; Kennedy A
    Infect Control Hosp Epidemiol; 2000 Apr; 21(4):264-9. PubMed ID: 10782589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children.
    Leonardi S; Praticò AD; Lionetti E; Spina M; Vitaliti G; La Rosa M
    World J Gastroenterol; 2012 Oct; 18(40):5729-33. PubMed ID: 23155313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
    Boonnak K; Dhitavat J; Thantamnu N; Kosoltanapiwat N; Auayporn M; Jiang L; Puthavathana P; Pitisuttithum P
    Vaccine; 2017 Dec; 35(52):7339-7346. PubMed ID: 29157960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™.
    Van Mulder TJS; Withanage K; Beyers KCL; Vankerckhoven VVJ; Theeten H; Van Damme P
    Vaccine; 2019 Jan; 37(4):581-586. PubMed ID: 30587432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia.
    Ouma GO; Rodriguez E; Muthumani K; Weiner DB; Wilensky RL; Mohler ER
    J Vasc Surg; 2014 Mar; 59(3):786-93. PubMed ID: 23850058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults.
    Assantachai P; Niyomnaitham S; Chatthanawaree W; Intalapaporn S; Muangpaisan W; Phannarus H; Saichompoo RB; Sura-Amonrattana U; Wongprompitak P; Toh ZQ; Licciardi PV; Srisutthisamphan K; Chokephaibulkit K
    J Infect Dis; 2023 Oct; 228(7):868-877. PubMed ID: 37141388
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.
    Low L; Mander A; McCann K; Dearnaley D; Tjelle T; Mathiesen I; Stevenson F; Ottensmeier CH
    Hum Gene Ther; 2009 Nov; 20(11):1269-78. PubMed ID: 19619001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.
    Nougarede N; Bisceglia H; Rozières A; Goujon C; Boudet F; Laurent P; Vanbervliet B; Rodet K; Hennino A; Nicolas JF
    Hum Vaccin Immunother; 2014; 10(9):2713-20. PubMed ID: 25483667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integration of needle-free jet injection with advanced electroporation delivery enhances the magnitude, kinetics, and persistence of engineered DNA vaccine induced immune responses.
    Jiang J; Ramos SJ; Bangalore P; Fisher P; Germar K; Lee BK; Williamson D; Kemme A; Schade E; McCoy J; Muthumani K; Weiner DB; Humeau LM; Broderick KE
    Vaccine; 2019 Jun; 37(29):3832-3839. PubMed ID: 31174938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
    Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
    Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects.
    Vardas E; Stanescu I; Leinonen M; Ellefsen K; Pantaleo G; Valtavaara M; Ustav M; Reijonen K
    Vaccine; 2012 Jun; 30(27):4046-54. PubMed ID: 22549090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
    Clarke DK; Xu R; Matassov D; Latham TE; Ota-Setlik A; Gerardi CS; Luckay A; Witko SE; Hermida L; Higgins T; Tremblay M; Sciotto-Brown S; Chen T; Egan MA; Rusnak JM; Ward LA; Eldridge JH
    Lancet Infect Dis; 2020 Apr; 20(4):455-466. PubMed ID: 31952923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.